Alethea Capital Management »

Tempus Ai shares owned by Alethea Capital Management

Quarter-by-quarter ownership of Tempus Ai (TEM) shares owned by Alethea Capital Management from 13F filings

Historical chart of Alethea Capital Management investment in Tempus Ai

Tip: Access up to 7 years of quarterly data

All positions including Tempus Ai held by Alethea Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempus Ai by Alethea Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 32k 59.05

More positions owned by Alethea Capital Management

Axsome Therapeutics (AXSM)
Avidity Biosciences Ord (RNA)
Spdr Series Trust State Street Spd (BIL)
Kura Oncology (KURA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tempus Ai Cl A (TEM)
Cidara Therapeutics Com New (CDTX)
Wisdomtree Tr Europe Hedged Eq (HEDJ)
Invesco Exchange Traded Fd T S&p500 Eql Utl (RSPU)
Immuneering Corp Class A Com (IMRX)
Taseko Cad (TGB)
Open Lending Corp (LPRO)

View all positions for Alethea Capital Management

Top funds holding Tempus Ai

Vanguard Group
Susquehanna International
Baillie Gifford & Co
ARK Investment Management
BlackRock
Catalytic Wealth RIA
D. E. Shaw & Co
Softbank Group Corp
Jane Street
Jpmorgan Chase & Co
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Goldman Sachs Group
Geode Capital Management

View all funds holding Tempus Ai